BiomimX is a pioneer in Organ on a Chip (OoC) technology, producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing. Its proprietary platform, uBeat®, integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to produce “Beating Organs on Chip”. These recapitulate, with unprecedented precision and predictability, clinically relevant models reflective of human patho-physiology, amenable for drug safety and efficacy testing. A key highlight is uHeart, BiomimX leading platform validated for predicting cardiotoxicity. In addition to uHeart, BiomimX has developed 3 validated models (cardio-fibrosis, gut, and knee) and is actively working on liver and lung models, all of which replicate human physiology and patho-physiology with unprecedented precision. To know more
